Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Congenica expands in North America with strategic appointment

    Jan 17, 2017, 11:07 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Jan 17, 2017 - Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha O’Brien as its Chief Business Officer
    Full story
  • Novogene Purchases 10 PacBio Sequel Systems

    Jan 16, 2017, 15:35 PM by Michael Croft
    Bio-IT World Brief | Novogene today announced its intention to purchase 10 Sequel Systems for whole genome sequencing, Iso-Seq annotation and targeted sequencing services from Pacific Biosciences.
    Full story
  • The Stem-Cell Revolution Is Coming — Slowly

    Jan 16, 2017, 13:40 PM by Michael Croft
    The New York Times | Where are the miracle treatments we were promised? A Nobel Prize-winning scientist explains.
    Full story
  • Biotech IPO Master Is Still Setting Up New Biotechs And Hatching More Deals

    Jan 13, 2017, 14:08 PM by Michael Croft
    ENDPOINTS NEWS | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers.
    Full story
  • IDBS launches The E-WorkBook Cloud: combining the most powerful R&D software platform with the benefits and flexibility of the cloud

    Jan 13, 2017, 07:38 AM by Michael Croft
    BOSTON & LONDON, US & UK - Jan 12, 2017 - IDBS has today launched The E-WorkBook Cloud, an enterprise, Cloud-based platform designed specifically to meet the future challenges of scientific and R&D data management
    Full story
  • JP Morgan News Round Up

    Jan 12, 2017, 12:25 PM by Michael Croft

    Bio-IT World Brief | The JP Morgan Healthcare Conference was held this week in San Francisco, kicking off 2017 with news and deals and product announcements. Many presentations were webcast. Here are some of the highlights and news bits we’ve collected over the past three days.

    Full story
  • Creative Peptides Added Specific Peptide Synthesis and Related Services

    Jan 11, 2017, 04:52 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jan 11, 2017 - Creative Peptides optimized its synthesis services by adding more specific peptide synthesis, and three categories are included-GMP peptide synthesis, glycopeptides synthesis, Cell-Penetrating Peptides Synthesis
    Full story
  • Certara Launches Version 16 of its Simcyp Population-based Simulator

    Jan 10, 2017, 08:23 AM by Michael Croft
    PRINCETON, NJ - Jan 10, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has released version 16 of its Simcyp® Population-based Simulator
    Full story
  • Illumina Launches NovaSeq Sequencers, Aiming To Replace 1900 Sequencers

    Jan 9, 2017, 19:55 PM by Michael Croft
    Bio-IT World Speaking at the J.P. Morgan Healthcare Conference this afternoon, Francis deSouza, President and CEO of Illumina, unveiled the NovaSeq series, a new and scalable sequencing architecture, comprised of two instruments: the NovaSeq 5000 and NovaSeq 6000.
    Full story
  • Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline

    Jan 9, 2017, 19:15 PM by Michael Croft
    Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.
    Full story
  • PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance Cornerstone

    Jan 9, 2017, 16:43 PM by Michael Croft
    Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
    Full story
  • Will Our Government’s Multi-Billion-Dollar Investment In Genome Science Pay Off?

    Jan 9, 2017, 15:51 PM by Michael Croft
    Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.
    Full story
  • Interference: A CRISPR Patent Dispute Roadmap

    Jan 9, 2017, 10:10 AM by Michael Croft

    Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.

    Full story
  • Submissions Open for the 2017 Reaxys PhD Prize

    Jan 9, 2017, 06:48 AM by Michael Croft
    NEW YORK, NY, USA - Jan 9, 2017 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the 2017 Reaxys PhD Prize is open for submissions from young chemists from institutions around the world
    Full story
  • Guide RNA Synthesis Firm Synthego Gets Investment, Vote Of Doudna Confidence

    Jan 6, 2017, 10:55 AM by Michael Croft
    Bio-IT World This week Synthego, a leading provider of genome engineering solutions, announced a $41 million Series B financing, bringing the company’s total fundraising to $50 million. The latest round includes investment from several venture firms, as well as direct, individual investments from Jennifer Doudna and Jamie Cate.
    Full story
  • BioTeam’s Berman Charts 2017 HPC Trends in Life Sciences

    Jan 6, 2017, 09:26 AM by Michael Croft
    HPCwire | Twenty years ago high performance computing was nearly absent from life sciences. Today it's used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM).
    Full story
  • Bio Data Bridges Awarded Funding for Recombinant Proteomic Data Resource

    Jan 5, 2017, 14:36 PM by Michael Croft
    SEATTLE, WA, UNITED STATES - Jan 5, 2017 - Transform Research, LLC dba Bio Data Bridges, a life science software and knowledge management company, received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences (NIGMS)
    Full story
  • Core Informatics Releases Sanger Sequencing and Microarray Genotyping Apps

    Jan 5, 2017, 13:07 PM by Michael Croft
    BRANFORD, CT, UNITED STATES - Jan 5, 2017 - Core Informatics today announced the release of two new genomics workflow solutions for use on the Platform for Science
    Full story
  • Boston Biotech Pieris Nabs Cancer Deal With French Powerhouse Servier

    Jan 5, 2017, 12:20 PM by Michael Croft

    Bio-IT World News Brief | Pieris and Servier today announced a broad collaboration in immuno-oncology. Under the collaboration, Pieris and Servier will initially pursue five bispecific therapeutic programs.

    Full story
  • WuXi NextCODE Chosen To Support Singapore Precision Medicine Pilot

    Jan 5, 2017, 07:00 AM by Michael Croft
    Bio-IT World | The National Heart Centre of Singapore (NHCS) has chosen WuXi NextCODE to support its 18-month proof-of-concept precision medicine project, focusing on cardiovascular disease.
    Full story
  • «
  • 331
  • 332
  • 333
  • 334 (current)
  • 335
  • 336
  • 337
  • 338
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy